Day One Biopharmaceuticals (NASDAQ:DAWN) Hits New 12-Month Low Following Analyst Downgrade
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s share price hit a new 52-week low during trading on Thursday after Needham & Company LLC lowered their price target on the stock from $30.00 to $27.00. Needham & Company LLC currently has a buy rating on the stock. Day One Biopharmaceuticals traded as low as […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s share price hit a new 52-week low during trading on Thursday after Needham & Company LLC lowered their price target on the stock from $30.00 to $27.00. Needham & Company LLC currently has a buy rating on the stock. Day One Biopharmaceuticals traded as low as […]
